Lomefloxacin (SC-47111 or NY-198). Comparative antimicrobial activity against 2002 clinical isolates from hospitals in Mexico City.
作者信息
Durazo F, Resano F, Gonzalez M A
机构信息
Hospital Mocel, Mexico City, Mexico.
出版信息
Diagn Microbiol Infect Dis. 1990 Jan-Feb;13(1):71-5. doi: 10.1016/0732-8893(90)90058-4.
PMID:2331854
Abstract
A new difluorinated quinolone, lomefloxacin, was shown to have potent in vitro activity against a broad spectrum of bacteria, including multiresistant strains isolated from patients with severe infections in three hospitals in Mexico City. Whereas its activity was comparable to that of another fluoroquinolone (enoxacin), the pharmacokinetic advantages offered by lomefloxacin may be a significant benefit in clinical use.
摘要
相似文献
1
Lomefloxacin (SC-47111 or NY-198). Comparative antimicrobial activity against 2002 clinical isolates from hospitals in Mexico City.
Diagn Microbiol Infect Dis. 1990 Jan-Feb;13(1):71-5. doi: 10.1016/0732-8893(90)90058-4.
2
Comparative in vitro activity of lomefloxacin (SC 47111 or NY-198) against fresh clinical bacterial isolates.洛美沙星（SC 47111或NY - 198）对新鲜临床分离细菌的体外活性比较
Diagn Microbiol Infect Dis. 1989 May-Jun;12(3 Suppl):7S-11S. doi: 10.1016/0732-8893(89)90058-8.
3
Antimicrobial activity of lomefloxacin (NY-198, SC 47111) against bacterial strains from Venezuela.洛美沙星（NY - 198，SC 47111）对来自委内瑞拉的细菌菌株的抗菌活性。
Diagn Microbiol Infect Dis. 1989 May-Jun;12(3 Suppl):41S-43S. doi: 10.1016/0732-8893(89)90064-3.
4
[In vitro evaluation of lomefloxacin].[洛美沙星的体外评价]
Arzneimittelforschung. 1989 Aug;39(8):832-5.
5
Lomefloxacin, a new fluoroquinolone. Studies on in vitro antimicrobial spectrum, potency, and development of resistance.洛美沙星，一种新型氟喹诺酮类药物。体外抗菌谱、效力及耐药性发展的研究。
Diagn Microbiol Infect Dis. 1989 May-Jun;12(3):221-33. doi: 10.1016/0732-8893(89)90019-9.
6
A ten-laboratory study of lomefloxacin (NY-198 or SC 47111) antimicrobial activity in Argentina.在阿根廷进行的一项关于洛美沙星（NY - 198或SC 47111）抗菌活性的十实验室研究。
Diagn Microbiol Infect Dis. 1989 May-Jun;12(3 Suppl):45S-50S. doi: 10.1016/0732-8893(89)90065-5.
7
Multicenter in vitro evaluation of lomefloxacin (NY-198, SC-47111), including tests against nearly 7,000 bacterial isolates and preliminary recommendations for susceptibility testing.
Diagn Microbiol Infect Dis. 1988 Aug;10(4):221-40. doi: 10.1016/0732-8893(88)90094-6.
8
In vitro activity of lomefloxacin (SC 47111 or NY-198), a new quinolone antimicrobial, against clinical isolates of common pathogens.新型喹诺酮类抗菌药洛美沙星（SC 47111或NY - 198）对常见病原菌临床分离株的体外活性
Diagn Microbiol Infect Dis. 1989 May-Jun;12(3 Suppl):21S-28S. doi: 10.1016/0732-8893(89)90061-8.
9
In vitro evaluation of lomefloxacin (NY-198 or SC-47111), a new difluoro-quinolone.
J Chemother. 1989 Jul;1(4 Suppl):165-7.
引用本文的文献
1
Lomefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.洛美沙星。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1991 Dec;42(6):1018-60. doi: 10.2165/00003495-199142060-00009.
Zotero 插件